Feasibility, drug safety, and effectiveness of etiological treatment programs for Chagas disease in Honduras, Guatemala, and Bolivia: 10-year experience of Médecins Sans Frontières.
<h4>Background</h4>Chagas disease (American trypanosomiasis) is a zoonotic or anthropozoonotic disease caused by the parasite Trypanosoma cruzi. Predominantly affecting populations in poor areas of Latin America, medical care for this neglected disease is often lacking. Médecins Sans Fro...
Guardado en:
Autores principales: | Oliver Yun, M Angeles Lima, Tom Ellman, Wilma Chambi, Sandra Castillo, Laurence Flevaud, Paul Roddy, Fernando Parreño, Pedro Albajar Viñas, Pedro Pablo Palma |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c3b0b5f8cd5b4cfd8d5721fa32042e78 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Research in complex humanitarian emergencies: the Médecins Sans Frontières/Epicentre experience.
por: Vincent Brown, et al.
Publicado: (2008) -
Research ethics review in humanitarian contexts: the experience of the independent ethics review board of Médecins Sans Frontières.
por: Doris Schopper, et al.
Publicado: (2009) - Médecine
-
Assessing antimalarial efficacy in a time of change to artemisinin-based combination therapies: the role of Médecins Sans Frontières.
por: Jean-Paul Guthmann, et al.
Publicado: (2008) -
The costs of preventing and treating chagas disease in Colombia.
por: Marianela Castillo-Riquelme, et al.
Publicado: (2008)